title: Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
abstract: In China, hepatitis B virus (HBV) infection is the major cause of hepatocellular carcinoma (HCC), which is called HBV-related HCC (HBV-HCC), but the pathogenesis has not been clearly elucidated. Long non-coding RNAs (lncRNAs) have been paid increasing attention to, as an important regulatory molecule involved in many biological processes, as well as a variety of diseases. This study examined lncRNA that might play an important role in HBV-HCC pathogenesis by conducting lncRNA and mRNA profile comparison between HBV-HCC and normal liver tissues. The differentially expressed lncRNA and mRNA profiles between HBV-HCC and normal liver tissues were analyzed by microarrays. The potential protein-encoding gene regulated by lncRNA, and the biological function (gene ontology, pathway analysis) of the target gene were investigated. The results showed that the expression levels of lncRNA and mRNA in HBV-HCC tissues were different from those in normal liver tissues. As compared with normal liver tissue, 837 (4.30%) lncRNAs exhibited more than two-fold change (P<0.05); 325 were up-regulated, and 512 were down-regulated; 991 (5.70%) mRNAs exhibited more than 2-fold change (P<0.05); 733 were up-regulated and 258 were down-regulated in HBV-HCC tissue. Besides, there were 7 lncRNAs with above 10-fold elevation, 6 lncRNAs with above 10-fold decrease, 18 mRNAs with above 10-fold elevation and 11 mRNAs with above 10-fold decrease. 444 (53.05%) lncRNAs had their corresponding mRNAs, some of which were adjacent to lncRNAs. The biological analysis showed that the target gene of differentially expressed lncRNAs took part in the important biological regulatory function. Target gene-related pathway analysis revealed the pathways in carcinoma and mitogen-activated protein kinase (MAPK) signaling pathways significantly changed in the HBV-HCC tissues as compared with normal liver tissues (P<0.05). It was suggested that as compared with normal liver tissues, the expression of lncRNAs in HBV-HCC tissues changed significantly, and lncRNAs played a key role in the pathogenesis of HBV-HCC probably by mainly regulating the carcinoma-related signaling pathway and MAPK signaling pathways.
authors: Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. panfirstfeng@163.com.
authors: Yan-Feng
authors: YF
authors: Pan
authors: Department of Hepatobiliary Pancreatic Surgery, the People's Hospital of Zhengzhou University, Zhengzhou, 450003, China.
authors: Tao
authors: T
authors: Qin
authors: Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
authors: Lei
authors: L
authors: Feng
authors: Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
authors: Zu-Jiang
authors: ZJ
authors: Yu
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000235:genetics*; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D006509:Hepatitis B / Q000150:complications / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D062085:RNA, Long Noncoding / Q000235:genetics*
chemical_list: D062085:RNA, Long Noncoding
references: Mol Cancer Res. 2012 Oct;10(10):1319-31
references: 22912335
references: Nat Rev Genet. 2009 Mar;10(3):155-9
references: 19188922
references: Int J Cancer. 2009 Jan 15;124(2):287-97
references: 19003969
references: CA Cancer J Clin. 2012 Nov-Dec;62(6):394-9
references: 23070690
references: J Clin Lab Anal. 2011;25(5):350-3
references: 21919070
references: Oncol Rep. 2009 Apr;21(4):957-69
references: 19287994
references: Eur J Cancer. 2011 Feb;47(3):333-8
references: 21112773
references: Bioinformatics. 2008 Nov 15;24(22):2657-63
references: 18434344
references: Curr Opin Cell Biol. 2009 Jun;21(3):416-25
references: 19447594
references: Mol Cancer. 2011 Apr 13;10:38
references: 21489289
references: World J Gastroenterol. 2012 Apr 14;18(14):1590-601
references: 22529687
references: Oncogene. 2010 Sep 9;29(36):4989-5005
references: 20639898
references: Genes Dev. 2009 Aug 15;23(16):1831-42
references: 19684108
references: Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72
references: 19571010
references: Nat Rev Cancer. 2006 Sep;6(9):674-87
references: 16929323
references: Int J Biochem Cell Biol. 2010 Jul;42(7):1115-22
references: 20348013
references: J Invest Dermatol. 2007 Jul;127(7):1622-31
references: 17380110
references: Gastroenterology. 2007 Jan;132(1):330-42
references: 17241883
references: RNA. 2010 Aug;16(8):1478-87
references: 20587619
references: Hepatology. 2010 Nov;52(5):1680-9
references: 20725905
references: Cell. 2009 Feb 20;136(4):629-41
references: 19239885
references: Hum Mol Genet. 2010 Oct 15;19(R2):R152-61
references: 20729297
references: Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R17-29
references: 16651366
references: Curr Opin Cell Biol. 2010 Jun;22(3):357-64
references: 20356723